KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Return on Equity (2016 - 2025)

Gilead Sciences (GILD) has disclosed Return on Equity for 17 consecutive years, with 0.33% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Return on Equity rose 27.0% year-over-year to 0.33%, compared with a TTM value of 0.33% through Jun 2025, up 27.0%, and an annual FY2024 reading of 0.02%, down 23.0% over the prior year.
  • Return on Equity was 0.33% for Q2 2025 at Gilead Sciences, up from 0.31% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.33% in Q2 2025 and bottomed at 0.01% in Q3 2024.
  • Average Return on Equity over 5 years is 0.18%, with a median of 0.22% recorded in 2022.
  • The sharpest move saw Return on Equity decreased -26bps in 2024, then increased 29bps in 2025.
  • Year by year, Return on Equity stood at 0.27% in 2021, then dropped by -19bps to 0.22% in 2022, then increased by 15bps to 0.25% in 2023, then plummeted by -90bps to 0.03% in 2024, then surged by 1182bps to 0.33% in 2025.
  • Business Quant data shows Return on Equity for GILD at 0.33% in Q2 2025, 0.31% in Q1 2025, and 0.03% in Q4 2024.